UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 
Commission File Number: 001-40067
 
PARDES BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
 
2137 Salk Avenue, Suite 250
PMB#052
Carlsbad, CA
(415) 649-8758
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
 
Common stock, par value $0.0001
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which
a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 
Rule 12g-4(a)(1)
☒
 
Rule 12g-4(a)(2)
☐
 
Rule 12h-3(b)(1)(i)
☒
 
Rule 12h-3(b)(1)(ii)
☐
 
Rule 15d-6
 ☐
 
Rule 15d-22(b)
 ☐

Approximate number of holders of record as of the certification or notice date:  One

Pursuant to the requirements of the Securities Exchange Act of 1934, Pardes Biosciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 
PARDES BIOSCIENCES, INC.
     
Date: September 11, 2023
By:
/s/ James B. Tananbaum
 
Name:
James B. Tananbaum
 
Title:
President and Chief Executive Officer


Pardes Biosciences (NASDAQ:PRDS)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Pardes Biosciences Charts.
Pardes Biosciences (NASDAQ:PRDS)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Pardes Biosciences Charts.